Canadian - U.S. Dietary Reference Intakes Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NIDDK, OD/ DPCPSI
|
2005
|
|
Cancer Diagnostic Devices Interagency Task Force (CD2) - MOU among NCI, FDA, HRSA
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
|
2021
|
|
Cancer Moonshot Award
|
Research Initiative
|
OS
|
NCI, NIDCD
|
2019
|
|
CCDI Molecular Target Platform
|
Resource Development
|
FDA
|
|
2021
|
|
CDC Acute Flaccid Myelitis Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NINDS
|
2018
|
|
CDC Integration with GrantSolutions
|
Resource Development
|
ACF, CDC
|
OD/ OER
|
2016
|
|
CDC Office of Public Health Genomics
|
Public Education Campaign
|
CDC
|
NHLBI
|
2017
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
2008
|
|
Center for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) Opioids Work Group (OWG)
|
Committee, Advisory Group, or Work Group
|
CMS
|
NIDA, NCCIH, NINDS, NIMH
|
2018
|
|
Cervical Cancer Moonshot Federal Interagency Partners Team
|
Committee, Advisory Group, or Work Group
|
HRSA, CDC
|
|
2021
|
|
Cervical screening guidelines
|
Resource Development
|
CDC, HRSA, FDA
|
|
2019
|
|
CFAR Diversity, Equity, Inclusion Pipeline Initiative (CDEIPI)
|
Research Initiative
|
OASH
|
NIAID, NIMH, NCI, NHLBI, NIDDK, NINR, NIDCR, NIMHD, NICHD, NIA, FIC, OD/ DPCPSI/ OAR
|
2021
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
Chronic Kidney Disease Surveillance System
|
Health Survey
|
CDC
|
|
2006
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
|
2018
|
|
CISA: Clinical Immunization Safety Assessment Network (CISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NHLBI
|
2021
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical and Translational Serology Task Force (CTTF)
|
Resource Development
|
CDC, FDA, ASPR
|
NCI, NIAID
|
2021
|
|
Clinical Decision Support Connect Work Group (CDS Connect Work Group)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, ONC
|
NCI, NLM
|
2015
|
|
Clinical Genome Resource and Genetic Testing Reference Material Program Collaborative Project (ClinGen and GeT-RM Collaborative Project)
|
Resource Development
|
CDC
|
|
2021
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Research Using Medicare Data from the Virtual Research Data Center (VRDC)
|
Research Initiative
|
CMS
|
NLM
|
2016
|
|
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2013
|
|
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, IOS
|
NLM
|
2008
|
|
CMS End-stage Renal Disease (ESRD) Affinity Group
|
Committee, Advisory Group, or Work Group
|
CMS
|
|
2016
|
|
CMS-NIH Leadership Council
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIDA, NIDDK, NIMHD, OD/ IMOD, OD/ OER, OD/ OSP
|
2011
|
|
CMS/NIH/NHLBI Sickle Cell Disease Working Group
|
Meeting/ Workshop
|
CMS
|
|
2021
|
|
Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2020
|
|
Collaborative Acute Toxicity Modeling Suite (CATMoS)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NCATS
|
2018
|
|
Collaborative on Healthy Parenting in Primary Care
|
Public Education Campaign
|
CDC, HRSA, SAMHSA
|
NICHD
|
|
|
Collaborative Use Repurposing Engine ID (CURE ID)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Combating Antibiotic Resistant Bacteria (CARB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NIAID
|
2015
|
|
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee (CARBx-JOC)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC
|
NIAID
|
2016
|
|
Community Engagement Alliance Against COVID-19 Disparities (CEAL) Initiative
|
Research Initiative
|
AoA
|
NICHD
|
2020
|
|
Community Guide Cardiovascular Coordination Team
|
Committee, Advisory Group, or Work Group
|
CDC
|
NHLBI
|
2013
|
|
Community Preventive Services Task Force (CPSTF)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, AHRQ, OASH, HRSA, IHS, SAMHSA
|
OD/ DPCPSI
|
1996
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
|
2004
|
|
Congenital Heart Public Health Consortium
|
Resource Development
|
AHRQ, CDC
|
NHLBI
|
2008
|
|
Consumer Product Chemical Exposures in Pregnancy and Their Cumulative Impact on Disorders of Fetal Growth
|
Research Initiative
|
CDC
|
|
2020
|
|
Contract to fund Congressional mandated National Academies of Sciences, Engineering, and Medicine (NASEM) study on Organ Donation and Transplantation
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NHLBI, NIAID, NIDDK
|
2019
|
|
COPD National Action Plan
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, HRSA, IHS
|
NCI, NHLBI, NIA, NIEHS, NINR
|
2017
|
|
Council on Emergency Medical Care (CEMC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, HRSA, OS, SAMHSA
|
NCATS, NHLBI, NICHD, NIGMS, NINDS, NLM
|
2014
|
|
Countering Biothreats IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countering Biothreats sub-IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network (CounterACT Research Network)
|
Research Initiative
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, NLM
|
2006
|
|
Countermeasures Against Chemical Threats program (CounterACT)
|
Research Initiative
|
ASPR
|
NIAID, NIAMS, NICHD, NEI, NINDS, NIDA
|
2006
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening - Kenya
|
Other
|
CDC
|
FIC, NCI, NIAID
|
2013
|
|
Covid Serology Research and Results Tracker (SeroHub)
|
Resource Development
|
CDC
|
NCI, NIAID
|
2020
|
|
COVID Special Interest Group (SIG)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
COVID-19 Health and Safety Briefs
|
Training Initiative
|
CDC
|
|
2021
|
|
COVID-19 Open Data Portal
|
Research Initiative
|
ASPR
|
NIAID, NLM
|
2020
|
|
COVID-19 Scenario Modeling Hub (SMH)
|
Research Initiative
|
CDC
|
NIGMS
|
2020
|
|
COVID-19 Therapeutics Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIAID
|
2020
|
|
CTAC Ad hoc Strategic Planning Working Group (CTAC SPWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS
|
NCI
|
2019
|
|
Cytokine Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDCD
|
2007
|
|